XO Life is now brite health

October 23, 2026
Munich, Germany, October 23, 2026 — XO Life, one of Europe’s leading digital health platforms, today announced that it has officially rebranded as brite health. The change unifies the company under the name of its core product, the brite™ meta-platform, bringing the corporate identity in line with the brand that patients and partners already know.
The decision reflects the central role the brite™ platform has come to play in the company’s mission. brite is the first meta health platform to cover the full patient journey, from patient activation and diagnosis to therapy guidance and long-term adherence, across any condition, any medicine, and any market. As the independent patient network for pharma, it connects patients, doctors, and pharmaceutical companies on one platform. Operating under a single, recognizable name gives partners, patients, and the wider industry one clear identity to engage with.
“Our product and our company have been moving toward the same identity for some time, and this step makes it official,” says Dr. Friderike Bruchmann, Founder and CEO of brite health. “brite is the name our partners and patients recognize, and bringing the whole company under it reflects who we are and where we are headed.”
Nothing changes for the company’s partners and users beyond the name. The same team, platform, and commitments remain in place, now under a single brand. The company’s website has moved to brite.health and all communications, products, and services will carry the brite health name going forward. The XO Life name is being retired.
About brite health
brite health’s brite™ meta-platform is the first meta health platform covering the full patient journey, from patient activation to therapy guidance, across any condition, any medicine, and any market. As the independent patient network for pharma, it connects patients, doctors, and pharmaceutical companies on a single platform, free to use for both patients and healthcare professionals. As a shared platform, it enables manufacturers to offer their patients branded, personalized digital support, all in one unified app, with verified content, tailored insights, and expert advice, and without having to download a separate app for each product or company. brite health also works with the leading medical associations in Germany.
brite health is the market leader in the DACH region and works with 40 pharmaceutical companies, including five of the ten largest global pharma companies, across more than 60 indications. The brite™ platform is available worldwide and is helping to redefine digital patient engagement at scale.
Would you like to find out more or are you interested in XO Life?
Get in touch now, get a demo or answer individual questions in a personal conversation.
Discover even more news

brite™ Launches Nationwide Cooperation with Germany's Federal Association of Pulmonologists to Support Asthma and COPD Patients Digitally

XO Life Secures €4 Million in New Funding to Accelerate European Expansion and Scale its AI-Driven Patient-Pharma Platform
%20(1).jpg)
